Description:
A drug that targets the appetite control system in the brain could bring about significant weight loss in people with clinical obesity, according to new October 23, 2017
University of Leeds
Journal Reference:
John Blundell, Graham Finlayson, Mads Axelsen, Anne Flint, Catherine Gibbons, Trine Kvist, Julie B. Hjerpsted. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes, Obesity and Metabolism, 2017; 19 (9): 1242 DOI: 10.1111/dom.12932
No comments:
Post a Comment